Joel Linden, Ph.D. is a Professor in the Division of Developmental Immunology and a leading expert on adenosine receptors, which are important for regulating inflammation.
Linden received a B.S. from Brown University in Applied Mathematics and Biology and a Ph.D. from the University of Virginia in Pharmacology.
Linden has devoted the past 30 years to the study of the pharmacology, physiology and molecular biology of adenosine receptors and has co-authored over 200 papers and over 30 US patents on this subject. Dr. Linden has chaired several NIH study sections, and started a successful biopharmaceutical company, Adenosine Therapeutics.